venBio Global Strategic GP II, L.P., 10% Owner at Akero Therapeutics, Inc. (AKRO), sold 8,427 shares at $22.44 ($191K) on 2020-02-26, disclosed to the SEC on 2020-02-27.
Open-market sale of $191k AKRO by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.67 | 1,600 | $38K | 19.8% |
| 2 | $22.44 | 2,523 | $57K | 29.6% |
| 3 | $22.44 | 2,523 | $57K | 29.6% |
| 4 | $22.54 | 1,781 | $40K | 21.0% |
| Total | $22.69 avg | 8,427 | $191K | 100% |
| Filing → |